Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 216-407-3 | CAS number: 1576-35-8
Toxicological Summary
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.7 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- By inhalation
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 25
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 17.6 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- No inhalational study is available. A NOAEL of 10 mg/kg bw/d from a 90D oral toxicity study is converted to 7.9 mg/m3(10 mg/kg bw/d/0.38 m3/kg bw/d (rat inh vol for 8h) = 26.3 mg/m3and then further modified with a factor 6.7 m3/10 m3due to higher respiration volume during work. The modified starting point is then 17.6 mg/m3
- AF for dose response relationship:
- 1
- AF for differences in duration of exposure:
- 2
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Allometric scaling is not to be used as the dose level has been converted to inhalational concentration
- AF for other interspecies differences:
- 2.5
- AF for intraspecies differences:
- 5
- AF for the quality of the whole database:
- 1
- AF for remaining uncertainties:
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
- Most sensitive endpoint:
- acute toxicity
- Route of original study:
- By inhalation
DNEL related information
- Explanation for the modification of the dose descriptor starting point:
Data from an acute inhalation toxicity study (OECD 436) is availabe, an LC50 > 5 mg/L was identified. Based on this result, no specific DNEL for acute toxocity is considered necessary as the long-term DNEL would sufficiently protect against high short term peak exposure as well.
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.1 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- DNEL derivation method:
- other: ACGIH OEL value, read-across to hydrazine
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
- Most sensitive endpoint:
- acute toxicity
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.1 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 100
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 10 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- No dermal repeated dose toxicity studies are available. Data from a 90D oral toxicity study (OECD 408) is used where a NOAEL of 10 mg/kg bw/d was identified. As no data regarding skin absorption is available similar absorption after dermal exposes as after oral exposure is assumed as a worst-case scenario.
- AF for dose response relationship:
- 1
- AF for differences in duration of exposure:
- 2
- AF for interspecies differences (allometric scaling):
- 4
- AF for other interspecies differences:
- 2.5
- AF for intraspecies differences:
- 5
- AF for the quality of the whole database:
- 1
- AF for remaining uncertainties:
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- no DNEL required: short term exposure controlled by conditions for long-term
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
- Most sensitive endpoint:
- sensitisation (skin)
Acute/short term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - workers
p-TSH (T) and OBSH (S1) are both used as blowing agents in industrial processing and for professional uses.
For systemic effects from long term inhalational exposure, no inhalational study is available. A DNEL of 0.7 mg/m3 was established for p-TSH based read-across from a NOAEL of 10 mg/kg bw/d from an oral OECD 408 90D study with OBSH (S1).
For local effects in respiratory tract from long term inhalational exposure a DNEL of 0.1 mg/m3 is applicable based on a ACGIH TLV of 0.1 mg/m3 for OBSH (S1) derived to protect against effects from hydrazine liberated from hydrolysis of OBSH (S1). Due to close structural similarity to p-TSH (T) and a slower hydrolysis of p-TSH, a long term inhalational exposure a DNEL of 0.1 mg/m3 is considered sufficient to protect against peak concentrations of hydrazine for p-TSH as well.
For systemic effects from long term dermal exposure, no dermal study is available. A DNEL of 0.1 mg/kg/d was established for p-TSH based on read-across from a NOAEL of 10 mg/kg bw/d found in an oral OECD 408 90D study with OBSH (S1) in rats.
Short term exposure is controlled by conditions for long-term exposure, therefore no DNEL has been established. Further, as OBSH (S1) and p-TSH (T) has been identified as skin sensitizers, strict control measures should apply.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
No hazard can be identified for consumers and the general population as exposure is considered neglible. p-TSH is used as a blowing agent and during the foaming process, p-TSH decomposes into nitrogen and toluene-4-sulphonic acid which is further degraded during this process. Therefore, a direct consumer exposure is not likely to occur since p-TSH is not contained in final products.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Route: .live2